Mismatches outside exons 2 and 3 do not alter the peptide motif of the allele group B*44:02P

Human Immunology

Volumn 72, Issue 11, 2011, Pages 1039-1044

  Bade Doeding, Christina ^a   Cano, Pedro ^b   Huyton, Trevor ^a   Badrinath, Soumya ^a   Eiz Vesper, Britta ^a   Hiller, Oliver ^a   Blasczyk, Rainer ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Functional alleles; Peptide binding motif; Polymorphism; Stem cell transplantation

Indexed keywords

HLA B44 02 ANTIGEN; HLA B44 27 ANTIGEN; HLA B44 ANTIGEN; LENTIVIRUS VECTOR; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOBLAST; CELL STRAIN HEK293; ELECTROSPRAY MASS SPECTROMETRY; GENE CONVERSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN MOTIF;

AMINO ACID MOTIFS; B-LYMPHOCYTES; CELL LINE, TUMOR; CHROMATOGRAPHY, AFFINITY; DONOR SELECTION; EXONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HLA ANTIGENS; HLA-B ANTIGENS; HLA-B44 ANTIGEN; HUMANS; MUTATION; PEPTIDE FRAGMENTS; POLYMORPHISM, GENETIC; PROTEIN BINDING; TANDEM MASS SPECTROMETRY; TRANSGENES;

EID: 80054121332     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.08.004     Document Type: Article

References (18)

1. Chelvanayagam G. A roadmap for HLA-A, HLA-B, and HLA-C peptide binding specificities. Immunogenetics 1996, 45:15-26.
2. Saper M.A., Bjorkman P.J., Wiley D.C. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol 1991, 219:277-319.
3. Elamin N.E., Bade-Doeding C., Blasczyk R., Eiz-Vesper B. Polymorphism between HLA-A*0301 and A*0302 located outside the pocket F alters the POmega peptide motif. Tissue Antigens 2010, 76:487-490.
4. Bade-Doeding C., DeLuca D.S., Seltsam A., Blasczyk R., Eiz-Vesper B. Amino acid 95 causes strong alteration of peptide position Pomega in HLA-B*41 variants. Immunogenetics 2007, 59:253-259. [CrossRef].
5. Bade-Doeding C., Elsner H.A., Eiz-Vesper B., Seltsam A., Holtkamp U., Blasczyk R. A single amino-acid polymorphism in pocket A of HLA-A*6602 alters the auxiliary anchors compared with HLA-A*6601 ligands. Immunogenetics 2004, 56:83-88. [CrossRef].
6. Macdonald W.A., Purcell A.W., Mifsud N.A., Ely L.K., Williams D.S., Chang L., et al. A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. J Exp Med 2003, 198:679-691. [CrossRef].
7. Prilliman K.R., Jackson K.W., Lindsey M., Wang J., Crawford D., Hildebrand W.H. HLA-B15 peptide ligands are preferentially anchored at their C termini. J Immunol 1999, 162:7277-7284. [PubMed].
8. Barnstable C.J., Bodmer W.F., Brown G., Galfre G., Milstein C., Williams A.F., et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 1978, 14:9-20. [CrossRef].
9. Brodsky F.M., Parham P., Barnstable C.J., Crumpton M.J., Bodmer W.F. Monoclonal antibodies for analysis of the HLA system. Immunol Rev 1979, 47:3-61. [CrossRef].
10. Hirosawa M., Hoshida M., Ishikawa M., Toya T. MASCOT: multiple alignment system for protein sequences based on three-way dynamic programming. Comput Appl Biosci 1993, 9:161-167. [PubMed].
11. Bade-Doeding C., Theodossis A., Gras S., Kjer-Nielsen L., Eiz-Vesper B., Seltsam A., et al. The impact of human leucocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic family. Haematologica 2011, 96:110-118.
12. Fleischhauer K., Avila D., Vilbois F., Traversari C., Bordignon C., Wallny H.J. Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain. Tissue Antigens 1994, 44:311-317.
13. Lemmel C., Weik S., Eberle U., Dengjel J., Kratt T., Becker H.D., et al. Differential quantitative analysis of MHC ligands by mass spectrometry using stable isotope labeling. Nat Biotechnol 2004, 22:450-454. [CrossRef].
14. Wearsch P.A., Cresswell P. The quality control of MHC class I peptide loading. Curr Opin Cell Biol 2008, 20:624-631. [CrossRef].
15. Salter R.D., Benjamin R.J., Wesley P.K., Buxton S.E., Garrett T.P., Clayberger C., et al. A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2. Nature 1990, 345:41-46. [CrossRef].
16. Cano P., Fan B. A geometric and algebraic view of MHC-peptide complexes and their binding properties. BMC Struct Biol 2001, 1:2. [CrossRef].
17. Cano P., Fan B., Stass S. A geometric study of the amino acid sequence of class I HLA molecules. Immunogenetics 1998, 48:324-334. [CrossRef].
18. Gras S., Kjer-Nielsen L., Chen Z., Rossjohn J., McCluskey J. The structural bases of direct T-cell allorecognition: implications for T-cell-mediated transplant rejection. Immunol Cell Biol 2011, 89:388-395.